Immunotherapy of hepatocellular carcinoma with small double-stranded RNA

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide with limited therapeutic options. Since HCC has been shown to be immunogenic, immunotherapy is considered a promising therapeutic approach. Small interfering RNAs (siRNAs), depending on their structure and se...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabilova, Tatyana O, Kovtonyuk, Larisa V, Zonov, Evgeniy V, Ryabchikova, Elena I, Popova, Nelly A, Nikolin, Valeriy P, Kaledin, Vasiliy I, Zenkova, Marina A, Vlassov, Valentin V, Chernolovskaya, Elena L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038722/
https://www.ncbi.nlm.nih.gov/pubmed/24886485
http://dx.doi.org/10.1186/1471-2407-14-338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038722/
https://www.ncbi.nlm.nih.gov/pubmed/24886485
http://dx.doi.org/10.1186/1471-2407-14-338

Ejemplares similares